Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed world. Geriatric people are far more prone to conceal sarcopenia i.e. a noticeable rise in body fat with simultaneous loss of muscle mass and functional capability.
North America is forecast to account for more than 1/3 revenue share of the global obesity management market by 2017 and it should gain a substantial 224 BPS by the year 2025.
Market Analysis and Insights: Global Obesity Management Market
The global Obesity Management market size is projected to reach US$ 5820.4 million by 2026, from US$ 5535.3 million in 2020, at a CAGR of 4.8%% during 2021-2026.
Global Obesity Management Scope and Market Size
Obesity Management market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Obesity Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Roche
GlaxoSmithKline
Orexigen Therapeutics
Arena Pharmaceuticals
VIVUS
Novo Nordisk
...
Obesity Management Breakdown Data by Type
Drug
Surgery
Obesity Management Breakdown Data by Application
Hospitals
Speciality Clinics
Ambulatory Surgical Centres
Retail Pharmacies
North America is forecast to account for more than 1/3 revenue share of the global obesity management market by 2017 and it should gain a substantial 224 BPS by the year 2025.
Market Analysis and Insights: Global Obesity Management Market
The global Obesity Management market size is projected to reach US$ 5820.4 million by 2026, from US$ 5535.3 million in 2020, at a CAGR of 4.8%% during 2021-2026.
Global Obesity Management Scope and Market Size
Obesity Management market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Obesity Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Roche
GlaxoSmithKline
Orexigen Therapeutics
Arena Pharmaceuticals
VIVUS
Novo Nordisk
...
Obesity Management Breakdown Data by Type
Drug
Surgery
Obesity Management Breakdown Data by Application
Hospitals
Speciality Clinics
Ambulatory Surgical Centres
Retail Pharmacies
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Obesity Management Revenue
1.4 Market by Type
1.4.1 Global Obesity Management Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drug
1.4.3 Surgery
1.5 Market by Application
1.5.1 Global Obesity Management Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Speciality Clinics
1.5.4 Ambulatory Surgical Centres
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Obesity Management Market Perspective (2015-2026)
2.2 Global Obesity Management Growth Trends by Regions
2.2.1 Obesity Management Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Obesity Management Historic Market Share by Regions (2015-2020)
2.2.3 Obesity Management Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Obesity Management Market Growth Strategy
2.3.6 Primary Interviews with Key Obesity Management Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Obesity Management Players by Market Size
3.1.1 Global Top Obesity Management Players by Revenue (2015-2020)
3.1.2 Global Obesity Management Revenue Market Share by Players (2015-2020)
3.1.3 Global Obesity Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Obesity Management Market Concentration Ratio
3.2.1 Global Obesity Management Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Obesity Management Revenue in 2019
3.3 Obesity Management Key Players Head office and Area Served
3.4 Key Players Obesity Management Product Solution and Service
3.5 Date of Enter into Obesity Management Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Obesity Management Historic Market Size by Type (2015-2020)
4.2 Global Obesity Management Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Obesity Management Market Size by Application (2015-2020)
5.2 Global Obesity Management Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Obesity Management Market Size (2015-2020)
6.2 Obesity Management Key Players in North America (2019-2020)
6.3 North America Obesity Management Market Size by Type (2015-2020)
6.4 North America Obesity Management Market Size by Application (2015-2020)
7 Europe
7.1 Europe Obesity Management Market Size (2015-2020)
7.2 Obesity Management Key Players in Europe (2019-2020)
7.3 Europe Obesity Management Market Size by Type (2015-2020)
7.4 Europe Obesity Management Market Size by Application (2015-2020)
8 China
8.1 China Obesity Management Market Size (2015-2020)
8.2 Obesity Management Key Players in China (2019-2020)
8.3 China Obesity Management Market Size by Type (2015-2020)
8.4 China Obesity Management Market Size by Application (2015-2020)
9 Japan
9.1 Japan Obesity Management Market Size (2015-2020)
9.2 Obesity Management Key Players in Japan (2019-2020)
9.3 Japan Obesity Management Market Size by Type (2015-2020)
9.4 Japan Obesity Management Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Obesity Management Market Size (2015-2020)
10.2 Obesity Management Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Obesity Management Market Size by Type (2015-2020)
10.4 Southeast Asia Obesity Management Market Size by Application (2015-2020)
11 India
11.1 India Obesity Management Market Size (2015-2020)
11.2 Obesity Management Key Players in India (2019-2020)
11.3 India Obesity Management Market Size by Type (2015-2020)
11.4 India Obesity Management Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Obesity Management Market Size (2015-2020)
12.2 Obesity Management Key Players in Central & South America (2019-2020)
12.3 Central & South America Obesity Management Market Size by Type (2015-2020)
12.4 Central & South America Obesity Management Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Obesity Management Introduction
13.1.4 Roche Revenue in Obesity Management Business (2015-2020))
13.1.5 Roche Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Obesity Management Introduction
13.2.4 GlaxoSmithKline Revenue in Obesity Management Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Orexigen Therapeutics
13.3.1 Orexigen Therapeutics Company Details
13.3.2 Orexigen Therapeutics Business Overview
13.3.3 Orexigen Therapeutics Obesity Management Introduction
13.3.4 Orexigen Therapeutics Revenue in Obesity Management Business (2015-2020)
13.3.5 Orexigen Therapeutics Recent Development
13.4 Arena Pharmaceuticals
13.4.1 Arena Pharmaceuticals Company Details
13.4.2 Arena Pharmaceuticals Business Overview
13.4.3 Arena Pharmaceuticals Obesity Management Introduction
13.4.4 Arena Pharmaceuticals Revenue in Obesity Management Business (2015-2020)
13.4.5 Arena Pharmaceuticals Recent Development
13.5 VIVUS
13.5.1 VIVUS Company Details
13.5.2 VIVUS Business Overview
13.5.3 VIVUS Obesity Management Introduction
13.5.4 VIVUS Revenue in Obesity Management Business (2015-2020)
13.5.5 VIVUS Recent Development
13.6 Novo Nordisk
13.6.1 Novo Nordisk Company Details
13.6.2 Novo Nordisk Business Overview
13.6.3 Novo Nordisk Obesity Management Introduction
13.6.4 Novo Nordisk Revenue in Obesity Management Business (2015-2020)
13.6.5 Novo Nordisk Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Obesity Management Revenue
1.4 Market by Type
1.4.1 Global Obesity Management Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drug
1.4.3 Surgery
1.5 Market by Application
1.5.1 Global Obesity Management Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Speciality Clinics
1.5.4 Ambulatory Surgical Centres
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Obesity Management Market Perspective (2015-2026)
2.2 Global Obesity Management Growth Trends by Regions
2.2.1 Obesity Management Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Obesity Management Historic Market Share by Regions (2015-2020)
2.2.3 Obesity Management Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Obesity Management Market Growth Strategy
2.3.6 Primary Interviews with Key Obesity Management Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Obesity Management Players by Market Size
3.1.1 Global Top Obesity Management Players by Revenue (2015-2020)
3.1.2 Global Obesity Management Revenue Market Share by Players (2015-2020)
3.1.3 Global Obesity Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Obesity Management Market Concentration Ratio
3.2.1 Global Obesity Management Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Obesity Management Revenue in 2019
3.3 Obesity Management Key Players Head office and Area Served
3.4 Key Players Obesity Management Product Solution and Service
3.5 Date of Enter into Obesity Management Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Obesity Management Historic Market Size by Type (2015-2020)
4.2 Global Obesity Management Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Obesity Management Market Size by Application (2015-2020)
5.2 Global Obesity Management Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Obesity Management Market Size (2015-2020)
6.2 Obesity Management Key Players in North America (2019-2020)
6.3 North America Obesity Management Market Size by Type (2015-2020)
6.4 North America Obesity Management Market Size by Application (2015-2020)
7 Europe
7.1 Europe Obesity Management Market Size (2015-2020)
7.2 Obesity Management Key Players in Europe (2019-2020)
7.3 Europe Obesity Management Market Size by Type (2015-2020)
7.4 Europe Obesity Management Market Size by Application (2015-2020)
8 China
8.1 China Obesity Management Market Size (2015-2020)
8.2 Obesity Management Key Players in China (2019-2020)
8.3 China Obesity Management Market Size by Type (2015-2020)
8.4 China Obesity Management Market Size by Application (2015-2020)
9 Japan
9.1 Japan Obesity Management Market Size (2015-2020)
9.2 Obesity Management Key Players in Japan (2019-2020)
9.3 Japan Obesity Management Market Size by Type (2015-2020)
9.4 Japan Obesity Management Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Obesity Management Market Size (2015-2020)
10.2 Obesity Management Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Obesity Management Market Size by Type (2015-2020)
10.4 Southeast Asia Obesity Management Market Size by Application (2015-2020)
11 India
11.1 India Obesity Management Market Size (2015-2020)
11.2 Obesity Management Key Players in India (2019-2020)
11.3 India Obesity Management Market Size by Type (2015-2020)
11.4 India Obesity Management Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Obesity Management Market Size (2015-2020)
12.2 Obesity Management Key Players in Central & South America (2019-2020)
12.3 Central & South America Obesity Management Market Size by Type (2015-2020)
12.4 Central & South America Obesity Management Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Obesity Management Introduction
13.1.4 Roche Revenue in Obesity Management Business (2015-2020))
13.1.5 Roche Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Obesity Management Introduction
13.2.4 GlaxoSmithKline Revenue in Obesity Management Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Orexigen Therapeutics
13.3.1 Orexigen Therapeutics Company Details
13.3.2 Orexigen Therapeutics Business Overview
13.3.3 Orexigen Therapeutics Obesity Management Introduction
13.3.4 Orexigen Therapeutics Revenue in Obesity Management Business (2015-2020)
13.3.5 Orexigen Therapeutics Recent Development
13.4 Arena Pharmaceuticals
13.4.1 Arena Pharmaceuticals Company Details
13.4.2 Arena Pharmaceuticals Business Overview
13.4.3 Arena Pharmaceuticals Obesity Management Introduction
13.4.4 Arena Pharmaceuticals Revenue in Obesity Management Business (2015-2020)
13.4.5 Arena Pharmaceuticals Recent Development
13.5 VIVUS
13.5.1 VIVUS Company Details
13.5.2 VIVUS Business Overview
13.5.3 VIVUS Obesity Management Introduction
13.5.4 VIVUS Revenue in Obesity Management Business (2015-2020)
13.5.5 VIVUS Recent Development
13.6 Novo Nordisk
13.6.1 Novo Nordisk Company Details
13.6.2 Novo Nordisk Business Overview
13.6.3 Novo Nordisk Obesity Management Introduction
13.6.4 Novo Nordisk Revenue in Obesity Management Business (2015-2020)
13.6.5 Novo Nordisk Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
